Familial hyperlipidemia, more accurately called familial hypercholesterolemia or FH, is one of the most misunderstood cholesterol conditions in medicine.

Most people hear “genetic cholesterol problem” and assume the body is simply making too much cholesterol.

That is not the best way to understand FH.

FH is mainly a clearance problem. Your body is not clearing LDL particles from the blood the way it should. LDL particles are supposed to bind to LDL receptors, especially in the liver, so those particles can be pulled out of circulation and used, recycled, or broken down. In FH, that receptor pathway does not work as well. The result is more LDL staying in the bloodstream for longer periods of time. (NCBI)

That distinction matters.

LDL is not automatically “bad.” LDL particles carry cholesterol, fat-soluble nutrients, and other important cargo around the body. As we explain in why LDL is not the bad guy, the problem is not that LDL exists. The problem is when LDL cannot be cleared properly, cannot be utilized properly, and is exposed to too much oxidative stress, inflammation, blood sugar damage, toxins, and endothelial dysfunction.

That is when the terrain becomes dangerous.

What Is FH?

Familial hypercholesterolemia is an inherited condition that leads to high LDL cholesterol levels, often from childhood. The CDC describes FH as an inherited condition that causes high levels of LDL cholesterol and increases the risk of coronary artery disease and heart attack at younger ages. (CDC)

But again, the key is not simply “high LDL.”

The key is poor LDL clearance.

Think of LDL particles like delivery trucks. They carry important materials throughout the body. Once the delivery is complete, those trucks need docking stations where they can unload and be removed from circulation. Those docking stations are LDL receptors.

In FH, the docking system is impaired.

Sometimes there are not enough receptors. Sometimes the receptors do not bind LDL well. Sometimes they do not recycle properly. Sometimes PCSK9 causes the body to destroy too many LDL receptors. The outcome is similar: LDL particles remain in the blood longer than they should.

That is why FH is better understood as a receptor, clearance, and utilization problem.

How Common Is FH?

FH is not rare.

GeneReviews reports that heterozygous FH, where a person inherits one FH-related genetic variant, has traditionally been cited around 1 in 500 people, but newer data suggest it may be closer to 1 in 250. The CDC currently lists FH as affecting about 1 in 311 people. (NCBI) (CDC)

Homozygous FH, where a person inherits pathogenic variants from both parents, is much less common and much more serious. GeneReviews estimates homozygous FH at about 1 in 160,000 to 1 in 400,000 people. (NCBI)

That means many people walking around with very high LDL cholesterol may have a genetic clearance issue and not know it.

What Genes Are Involved?

The main FH genes are LDLR, APOB, and PCSK9.

LDLR is the gene for the LDL receptor. If the receptor is not made correctly, does not reach the cell surface, does not bind LDL properly, or does not recycle well, LDL clearance drops.

APOB is the gene for apolipoprotein B. ApoB is the major protein on LDL particles. It is like the “key” that helps LDL bind to the LDL receptor. If ApoB is altered, the LDL particle may not dock properly.

PCSK9 is a gene that affects how many LDL receptors stay available on liver cells. Gain-of-function PCSK9 variants can increase LDL receptor breakdown, leaving fewer receptors available to clear LDL. PCSK9 loss-of-function variants do the opposite: they increase LDL receptors, increase LDL removal, lower LDL-C, and are associated with lower CAD risk. (NCBI)

LDLRAP1 is another gene involved in a rarer autosomal recessive form of FH. In this case, the LDL receptor may be present, but the internalization process does not work correctly.

So FH is not really a “cholesterol production disease.” It is mainly a cholesterol clearance disease.

FH Is Also a Peripheral Utilization Problem

Most LDL clearance happens through the liver, but LDL receptors are found on many cells. These receptors allow cells to pull LDL particles out of circulation and use the cholesterol and fat-soluble cargo for normal biology.

That means FH can also be described as a problem with peripheral utilization of LDL. The LDL particle may be present. The cargo may be useful. But if the receptor system is impaired, the delivery truck cannot dock properly. The particle stays in circulation longer, and the longer it stays there, the more opportunity there is for oxidation, glycation, immune activation, and arterial injury.

This is why I do not like the simplistic message that “LDL is bad.” LDL is not bad. Broken LDL metabolism is bad. Poor clearance is bad. Oxidized LDL is bad. Endothelial dysfunction is bad. A damaged artery wall is bad.

The Natural Heart Doctor philosophy is simple: disease begins when the body is exposed to too much bad stuff and not enough good stuff. With FH, the genetic receptor issue may be real, but the terrain still matters.

What Repatha Does

Repatha, also known as evolocumab, is a PCSK9 inhibitor. According to the FDA label, evolocumab binds PCSK9 and prevents PCSK9 from binding to LDL receptors. This increases the number of LDL receptors available to clear LDL from the blood, which lowers LDL-C. (FDA label)

In plain English, Repatha lowers LDL numbers by improving LDL clearance. It is not just blocking cholesterol production. It is helping preserve the receptor system so more LDL particles can be removed from circulation.

But here is the problem: lowering the number is not the same as restoring the whole system. Repatha does not teach you why the arterial wall is inflamed. It does not remove the toxins. It does not fix insulin resistance. It does not repair the gut. It does not restore sleep, sunlight, movement, minerals, omega-3 status, or mitochondrial function. It does not rebuild the endothelium.

It can lower the number. But numbers are not the whole story. And if you have FH, you need to know the whole story. For more, see our guide to natural alternatives to PCSK9 inhibitors.

Why We Prefer OptiLipid as the Natural Next Step

At Natural Heart Doctor, we prefer to start with root-cause support whenever possible. That means supporting healthy lipid metabolism, LDL clearance, oxidative stress balance, inflammation resolution, blood sugar health, liver function, endothelial function, and the terrain around the artery wall.

That is why OptiLipid is the next logical step. OptiLipid contains seven botanicals: berberine, silymarin, green tea extract, curcumin, ginger, resveratrol, and quercetin — daily support for healthy cholesterol levels, LDL, HDL, triglycerides, inflammation, liver function, oxidative stress, and metabolic health.

Berberine is the anchor nutrient in this formula. Research suggests berberine may support LDL receptor expression, help reduce PCSK9 activity, and support better LDL clearance through the LDL receptor pathway. (PMC)

But OptiLipid does more than chase LDL. Curcumin, ginger, resveratrol, green tea extract, quercetin, and silymarin help support the inflammatory and oxidative stress pathways that determine whether LDL particles remain functional or become damaged. (MDPI)

That matters because LDL only becomes a major problem when it is trapped in the wrong terrain. If your blood sugar is high, LDL can become glycated. If oxidative stress is high, LDL can become oxidized. If the gut is leaky, immune activation rises. If toxins are high, the liver struggles. If the endothelium is damaged, the artery wall becomes more vulnerable.

FH gives you a clearance challenge. The modern lifestyle gives you an oxidation, inflammation, and endothelial challenge. You need to address both.

The FH Action Plan

If you have suspected or confirmed FH, do not panic and do not reduce the conversation to one number.

Start by confirming what is really going on. That may include ApoB, LDL particle number, Lp(a), oxidized LDL, hs-CRP, fasting insulin, A1c, homocysteine, omega-3 index, thyroid markers, liver markers, toxin testing, and genetic testing when appropriate.

Eat real food. Prioritize clean animal foods, wild seafood, organs, eggs, healthy fats, minerals, and polyphenol-rich plants. Avoid seed oils, processed foods, refined sugar, grains, and junk that damages the gut and arteries.

Live well. Get sunshine. Sleep deeply. Move daily. Build muscle. Sweat. Reduce environmental toxins. Fix water damage and mold exposure. Support the liver, the gut, and the mitochondria.

Think well. Chronic stress changes blood sugar, blood pressure, inflammation, sleep, HRV, and vascular tone. You cannot out-supplement a nervous system stuck in fight-or-flight.

Then support lipid metabolism naturally. For many people, OptiLipid is the next logical step. The standard serving on the product page is 1 capsule twice per day with food.

The Bottom Line

FH is real. Genes matter. But genes are not the whole story.

Familial hypercholesterolemia is not simply a disease of “too much cholesterol production.” It is mainly a problem of LDL clearance, receptor function, and LDL utilization. Repatha can lower LDL-C by improving LDL receptor availability through PCSK9 inhibition — but at Natural Heart Doctor, we do not stop at the number. We care about the terrain.

FH may load the gun. Modern living pulls the trigger. OptiLipid is our preferred natural next step to support healthy lipid metabolism, LDL clearance pathways, inflammation balance, oxidative stress protection, and arterial wellness. Because the goal is not just lower cholesterol. The goal is a stronger body, cleaner blood, healthier arteries, and a 100 Year Heart.